|
Hot Stocks
| ShowHide Related Items >><< - $2,278.70 /
-6.52 (-0.29%) - 06:13 Today
- Australia finds Google misled users over data collection
- 04/13/21
- Broadcom, Google Cloud to accelerate digital transformation in enterprise
- 04/12/21
- Nvidia announces partnerships for AI-on-5G platform
- 04/05/21
- Oracle says 'Google platform just got bigger' after Supreme Court ruling
- $2,291.00 /
-4.5 (-0.20%) - 06:13 Today
- Australia finds Google misled users over data collection
- 04/13/21
- Broadcom, Google Cloud to accelerate digital transformation in enterprise
- 04/12/21
- Nvidia announces partnerships for AI-on-5G platform
- 04/07/21
- LiveRamp Google in pact to enable identity in the Cloud
- $2,278.70 /
-6.52 (-0.29%) - 04/14/21 Wedbush
- Wedbush bullish on Alphabet, assumes coverage with an Outperform
- 04/13/21 Wedbush
- Alphabet assumed with Outperform, added to 'Best Ideas' at Wedbush
- 04/12/21 BMO Capital
- Microsoft price target raised to $280 from $270 at BMO Capital
- 04/09/21 Argus
- Alphabet price target raised to $2,500 from $2,400 at Argus
- $2,291.00 /
-4.5 (-0.20%) - 04/15/21 Cowen
- Alphabet price target raised to $2600 from $2400 at Cowen
- 04/14/21 Wedbush
- Wedbush bullish on Alphabet, assumes coverage with an Outperform
- 04/13/21 Wedbush
- Alphabet assumed with Outperform, added to 'Best Ideas' at Wedbush
- 04/05/21 Evercore ISI
- Alphabet assumed with an Outperform at Evercore ISI
- $2,278.70 /
-6.52 (-0.29%) - 02/16/21
- Tiger Global bought DoorDash and 1Life during Q4, sold out of Alphabet
- 02/02/21
- Alphabet reports Q4 EPS $22.30, consensus $15.90
- 02/02/21
- Notable companies reporting after market close
- 10/29/20
- Alphabet CFO sees signs user behavior beginning to return to normalized level
- $2,291.00 /
-4.5 (-0.20%) - 02/16/21
- Tiger Global bought DoorDash and 1Life during Q4, sold out of Alphabet
- 02/02/21
- Alphabet reports Q4 EPS $22.30, consensus $15.90
- 02/02/21
- Notable companies reporting after market close
- 10/29/20
- Alphabet reports Q3 Traffic Acquisition Costs $8.17B vs. $7.49B a year ago
- $2,278.70 /
-6.52 (-0.29%) - 04/15/21
- House panel clears blueprint for big tech legislation, Reuters reports
- 04/15/21
- Daimler sees 'intense' competition if Apple enters EV market, CEO tells CNBC
- 04/14/21
- Google can now help order takeout from restaurants online, The Verge says
- 04/13/21
- Google, ADT expand partnership with pro Nest installation, CNET reports
- $2,291.00 /
-4.5 (-0.20%) - 04/15/21
- House panel clears blueprint for big tech legislation, Reuters reports
- 04/15/21
- Daimler sees 'intense' competition if Apple enters EV market, CEO tells CNBC
- 04/14/21
- Google can now help order takeout from restaurants online, The Verge says
- 04/13/21
- Google, ADT expand partnership with pro Nest installation, CNET reports
- $2,278.70 /
-6.52 (-0.29%) - 04/14/21
- Alphabet coverage assumption, Facebook downgrade among top calls on Wall Street
- 04/07/21
- #SocialStocks: AR glasses seen as future of tech
- 04/07/21
- Game On: An exclusive talk with 'Genesis Noir' developer Feral Cat Den
- 04/06/21
- Roku, Starbucks initiations among today's top calls on Wall Street
- $2,291.00 /
-4.5 (-0.20%) - 04/14/21
- Alphabet coverage assumption, Facebook downgrade among top calls on Wall Street
- 04/07/21
- #SocialStocks: AR glasses seen as future of tech
- 04/07/21
- Game On: An exclusive talk with 'Genesis Noir' developer Feral Cat Den
- 04/06/21
- Roku, Starbucks initiations among today's top calls on Wall Street
- $2,278.70 /
-6.52 (-0.29%) - 04/01/21
- Unusually active option classes on open April 1st
- 02/03/21
- Early notable gainers among liquid option names on February 3rd
- 01/20/21
- Early notable gainers among liquid option names on January 20th
- 10/30/20
- Early notable gainers among liquid option names on October 30th
- $2,291.00 /
-4.5 (-0.20%) - 02/02/21
- Alphabet options imply 6.6% move in share price post-earnings
- 11/10/20
- Alphabet call volume above normal and directionally bullish
- 10/30/20
- Early notable gainers among liquid option names on October 30th
|
|
On The Fly
| ShowHide Related Items >><< - 09:36 Today
- Morgan Stanley says 'very active' in recruiting advisors
- 09:11 Today
- Morgan Stanley expects net interest income to grow from current levels
- 08:53 Today
- Morgan Stanley says investment banking pipelines 'healthy across products'
- 08:43 Today
- Morgan Stanley says Archegos exit 'money well spent'
- 04/14/21
- BNY Mellon chosen as transfer agent of Charles Schwab Investment Management
- 03/22/21
- AFL-CIO teams with Wilmington Trust, BNY Mellon on retirement plan options
- 02/16/21
- Amundi US appoints BNY Mellon as fund service provider
- 02/11/21
- BNY Mellon announces formation of new digital assets unit
- 06:27 Today
- Citizens Financial CEO says 'confident' in outlook for balance of year
- 06:24 Today
- Citizens Financial reports Q1 net interest margin 2.76% vs. 3.10% a year ago
- 01/27/21
- Citizens announces consumer financing partnership with BJ's Wholesale Club
- 01/20/21
- Citizens Financial sees high single digit decrease in FY21 NIM
- 10:27 Today
- State Street raises FY fee revenue view to up 2.5%-4%
- 10:27 Today
- State Street sees NII $460M-$465M per quarter from here in 2021
- 10:27 Today
- State Street sees Q2 expenses up around 2.5% y/y
- 10:26 Today
- State Street sees fee revenues up 2%-3% y/y in Q2
- 07:12 Today
- AstraZeneca reports U.S. clearance of proposed acquisition of Alexion
- 03/26/21
- Arcutis Biotherapeutics announces updates to its executive team
- 03/16/21
- AstraZeneca withdraws FTC notification on Alexion deal, plans to refile
- 02/22/21
- Arcturus Therapeutics acquires exclusive license from Alexion
- 07:12 Today
- AstraZeneca reports U.S. clearance of proposed acquisition of Alexion
- 04/14/21
- Denmark to continue vaccine rollout without AstraZeneca COVID-19 vaccine
- 04/14/21
- AstraZeneca's Tagrisso approved in China in early lung cancer
- 04/12/21
- AstraZeneca's DARE-19 ph.3 trial of Farxiga in COVID-19 failed primary endpoint
- 04/15/21
- Evelo Biosciences appoints Luca Scavo as CFO, Julie McHugh to board of directors
- 04/15/21
- Merck to discontinue development of MRK-7110 in COVID-19 treatment
- 04/14/21
- EMA says 'expediting' evaluation of Johnson & Johnson COVID-19 vaccine
- 04/13/21
- J&J pauses vaccinations in all COVID-19 vaccine clinical trials
LSCC Lattice Semiconductor - 04/15/21
- Lattice Semiconductor to replace PTC in S&P 400 at open on 4/20
- 02/23/21
- Lattice Semiconductor announces $60M stock buyback
- 12/15/20
- Everspin Technologies CEO Kevin Conley to step down
- 12/08/20
- Lattice Semiconductor launches 2nd generation security solution FPGAA
- $170.26 /
+16.4 (+10.66%) - 12:00 Today
- PPG rises 10.3%
- 10:00 Today
- PPG rises 11.1%
- 09:47 Today
- PPG rises 10.4%
- 08:30 Today
- PPG says expects to complete the acquisitions of Tikkurila, Worwag during Q2
- 10:00 Today
- Alcoa rises 8.1%
- 04/15/21
- Alcoa jumps 2% to $33.50 after Q1 earnings beat
- 04/15/21
- Alcoa reports Q1 adjusted EBITDA $521M, up 44% from Q4
- 04/15/21
- Alcoa expecting strong 2021 on continued economic recovery
- 02/08/21
- Editas Medicine appoints James Mullen as CEO
- 01/11/21
- Editas Medicine Chief Scientific Officer Charles Albright, Ph.D to step down
- 01/11/21
- Editas Medicine says FDA clears initiation of EDIT-301 clinical trial
- 12/21/20
- Editas leads gene editing stocks higher with 46% rally to $95.42
- 09:43 Today
- Splunk slides 7% after Chief Technology Officer resigns
- 04/14/21
- Carahsoft agreement for Splunk solutions designated CETA by DoD
- 04/13/21
- Splunk CEO sells 15.5K shares of common stock
- 04/05/21
- Splunk appoints Teresa Carlson as Chief Growth Officer
- 04/09/21 JMP Securities
- Goldman Sachs price target raised to $400 from $338 at JMP Securities
- 04/07/21 Barclays
- Morgan Stanley price target raised to $98 from $95 at Barclays
- 04/01/21 Deutsche Bank
- Morgan Stanley price target raised to $79 from $68 at Deutsche Bank
- 04/01/21 UBS
- Morgan Stanley price target raised to $92 from $84 at UBS
- 04/09/21 Deutsche Bank
- BNY Mellon price target raised to $54 from $50 at Deutsche Bank
- 04/07/21 Barclays
- BNY Mellon price target raised to $57 from $55 at Barclays
- 03/26/21 JPMorgan
- JPMorgan sees BNY Mellon, Wells Fargo among banks with most buyback capacity
- 03/24/21
- Fly Intel: Top five analyst upgrades
- 04/09/21 Jefferies
- Citizens Financial price target raised to $47 from $42 at Jefferies
- 04/07/21 Barclays
- Citizens Financial price target raised to $54 from $49 at Barclays
- 04/01/21 Deutsche Bank
- Citizens Financial price target raised to $50 from $44 at Deutsche Bank
- 03/30/21 Stephens
- Citizens Financial price target raised to $54 from $45 at Stephens
- 04/09/21 Deutsche Bank
- State Street price target raised to $100 from $97 at Deutsche Bank
- 04/07/21 Barclays
- State Street price target raised to $104 from $99 at Barclays
- 04/01/21 Wells Fargo
- State Street price target raised to $90 from $83 at Wells Fargo
- 04/01/21 Morgan Stanley
- State Street price target raised to $103 from $102 at Morgan Stanley
- 03/23/21
- Fly Intel: Top five analyst downgrades
- 03/23/21 SVB Leerink
- SVB Leerink moving to sidelines on Alexion, five others on industry concerns
- 03/23/21 SVB Leerink
- Alexion downgraded to Market Perform from Outperform at SVB Leerink
- 02/04/21 Piper Sandler
- Alexion downgraded to Neutral ahead of expected deal closing at Piper Sandler
- 04/14/21 Guggenheim
- Emergent BioSolutions price target lowered to $110 from $130 at Guggenheim
- 04/12/21
- Fly Intel: Top five analyst downgrades
- 04/12/21 B. Riley
- B. Riley calls Agenus the next Seagen, reiterates $8 target
- 04/12/21 Argus
- AstraZeneca downgraded to Hold from Buy at Argus
- 04/14/21 Guggenheim
- Emergent BioSolutions price target lowered to $110 from $130 at Guggenheim
- 04/13/21 Goldman Sachs
- J&J vaccine had numerical blood clot imbalance in trial, says Goldman Sachs
- 04/13/21 Morgan Stanley
- Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers
- 04/13/21 JPMorgan
- Vaccine pause 'incremental negative' for J&J, says JPMorgan
LSCC Lattice Semiconductor - 02/17/21 Craig-Hallum
- Lattice Semiconductor price target raised to $40 from $31 at Craig-Hallum
- 02/17/21 KeyBanc
- Lattice Semiconductor price target raised to $57 from $50 at KeyBanc
- 02/17/21 Cowen
- Lattice Semiconductor price target raised to $56 from $48 at Cowen
- 02/17/21 Susquehanna
- Lattice Semiconductor price target raised to $56 from $52 at Susquehanna
- $170.26 /
+16.4 (+10.66%) - 04/15/21 Citi
- Citi opens '30-day negative catalyst watch' on Axalta, PPG
- 04/07/21 Wells Fargo
- PPG price target raised to $173 from $165 at Wells Fargo
- 03/15/21 Credit Suisse
- PPG assumed with a Neutral at Credit Suisse
- 01/26/21 BofA
- PPG upgraded to Buy from Neutral at BofA
- 08:17 Today B. Riley
- Alcoa price target raised to $36 from $20 at B. Riley
- 07:34 Today BMO Capital
- Alcoa price target raised to $38 from $36 at BMO Capital
- 03/24/21
- Fly Intel: Top five analyst upgrades
- 03/24/21 Morgan Stanley
- Morgan Stanley upgrades Alcoa to Overweight on better prospects for aluminum
- 09:55 Today
- Fly Intel: Top five analyst initiations
- 04:56 Today Goldman Sachs
- Editas Medicine initiated with a Sell at Goldman Sachs
- 03/22/21 Credit Suisse
- Editas Medicine initiated with an Outperform at Credit Suisse
- 03/17/21 Guggenheim
- Editas Medicine assumed with a Neutral at Guggenheim
- 09:54 Today
- Fly Intel: Top five analyst downgrades
- 05:18 Today KeyBanc
- Splunk downgraded to Sector Weight from Overweight at KeyBanc
- 04/08/21 BofA
- Splunk reinstated with a Buy at BofA
- 04/08/21 BofA
- Splunk reinstated with a Buy at BofA
- 07:34 Today
- Morgan Stanley reports Q1 EPS $2.19, consensus $1.70
- 04/15/21
- Notable companies reporting before tomorrow's open
- 04/15/21
- Notable companies reporting before tomorrow's open
- 04/14/21
- Fly Intel: What to watch in next round of big bank earnings reports
- 06:34 Today
- BNY Mellon reports Q1 EPS 97c, consensus 87c
- 04/15/21
- Notable companies reporting before tomorrow's open
- 04/15/21
- Notable companies reporting before tomorrow's open
- 01/20/21
- BNY Mellon reports Q4 ex-items EPS 96c, consensus 91c
- 06:23 Today
- Citizens Financial reports Q1 underlying EPS $1.41, consensus 97c
- 06:21 Today
- Citizens Financial reports Q1 underlying EPS $1.41, consensus 97c
- 04/15/21
- Notable companies reporting before tomorrow's open
- 04/15/21
- Notable companies reporting before tomorrow's open
- 07:44 Today
- State Street reports Q1 ex-items EPS $1.47, consensus $1.35
- 04/15/21
- Notable companies reporting before tomorrow's open
- 04/15/21
- Notable companies reporting before tomorrow's open
- 01/19/21
- State Street reports Q4 EPS $1.39, consensus $1.56
- 02/04/21
- Alexion reports Q4 EPS $2.96, consensus $2.56
- 02/04/21
- Alexion reports Q4 EPS $2.96, consensus $2.56
- 10/29/20
- Alexion raises 2020 non-GAAP EPS view to $11.70-$12.00 from $10.65-$10.95
- 10/29/20
- Alexion reports Q3 non-GAAP EPS $3.24, consensus $2.60
- 04/07/21
- EMA says benefits of AstraZeneca Covid vaccine outweigh side effects
- 02/11/21
- AstraZeneca sees FY21 core EPS $4.75-$5.00
- 02/11/21
- AstraZeneca reports Q4 core EPS $1.07, total revenue $7.41B
- 11/05/20
- AstraZeneca backs view for FY20 core EPS up by a mid- to high-teens percentage
- 01/26/21
- Johnson & Johnson sees FY21 adjusted operational EPS $9.25-$9.45
- 01/26/21
- Johnson & Johnson reports Q4 adjusted EPS $1.86, consensus $1.82
- 01/25/21
- Notable companies reporting before tomorrow's open
- 01/25/21
- Notable companies reporting before tomorrow's open
LSCC Lattice Semiconductor - 02/16/21
- Lattice Semiconductor sees Q1 revenue $106M-$114M, consensus $103.4M
- 02/16/21
- Lattice Semiconductor reports Q4 EPS 19c, consensus 17c
- 02/16/21
- Notable companies reporting after market close
- 10/27/20
- Lattice Semiconductor sees Q4 revenue $99M-$107M, consensus $101.24M
- $170.26 /
+16.4 (+10.66%) - 08:30 Today
- PPG sees Q2 adjusted EPS $2.15-$2.20, consensus $2.10
- 04/15/21
- PPG reports Q1 EPS $1.88, consensus $1.56
- 04/15/21
- Notable companies reporting after market close
- 01/22/21
- PPG sees Q1 adjusted EPS $1.55-$1.61, consensus $1.89
- 04/15/21
- Alcoa reports Q1 adjusted EPS 79c, consensus 46c
- 04/15/21
- Notable companies reporting after market close
- 01/20/21
- Alcoa reports Q4 adjusted EPS 26c, consensus 11c
- 01/20/21
- Notable companies reporting after market close
- 02/25/21
- Editas Medicine reports Q4 EPS ($1.00), consensus (74c)
- 11/05/20
- Editas Medicine reports Q3 EPS 12c, consensus (64c)
- 03/03/21
- Splunk sees Q1 revenue $480M-$500M, consensus $507.29M
- 03/03/21
- Splunk reports Q4 EPS (86c) vs (15c) last year
- 03/03/21
- Notable companies reporting after market close
- 12/02/20
- Splunk withdrawing FY23 ARR and operating cash flow targets
|